SOADOR
OFIX icon

State of Alaska Department of Revenue’s Orthofix Medical OFIX Stock Holding History

State of Alaska Department of Revenue’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Hold
2,102
– – ﹤0.01% 2106
2026
Q1 		$24K Hold
2,102
– – ﹤0.01% 2049
2025
Q4 		$31K Hold
2,102
– – ﹤0.01% 2008
2025
Q3 		$30K Buy
+2,102
New +$27.6K ﹤0.01% 1898
2023
Q4 		– Sell
-22,870
Closed -$294K – 1611
2023
Q3 		$294K Buy
22,870
+39
+0.2% +$702 ﹤0.01% 1531
2023
Q2 		$412K Sell
22,831
-577
-2% -$10.8K ﹤0.01% 1449
2023
Q1 		$392K Buy
23,408
+9,476
+68% +$185K ﹤0.01% 1466
2022
Q4 		$286K Buy
13,932
+82
+0.6% +$1.45K ﹤0.01% 1551
2022
Q3 		$264K Sell
13,850
-1,211
-8% -$27.2K ﹤0.01% 1546
2022
Q2 		$354K Buy
15,061
+1,330
+10% +$38.1K ﹤0.01% 1490
2022
Q1 		$449K Sell
13,731
-250
-2% -$8.03K ﹤0.01% 1432
2021
Q4 		$434K Sell
13,981
-390
-3% -$13K ﹤0.01% 1510
2021
Q3 		$547K Buy
14,371
+835
+6% +$33.2K 0.01% 1416
2021
Q2 		$542K Buy
13,536
+325
+2% +$13.7K 0.01% 1413
2021
Q1 		$572K Sell
13,211
-1,830
-12% -$80.7K 0.01% 1359
2020
Q4 		$646K Sell
15,041
-3,050
-17% -$111K 0.01% 1219
2020
Q3 		$563K Sell
18,091
-20
-0.1% -$620 0.01% 1176
2020
Q2 		$579K Buy
18,111
+440
+2% +$14.6K 0.01% 1165
2020
Q1 		$494K Buy
17,671
+3,285
+23% +$127K 0.01% 1118
2019
Q4 		$664K Sell
14,386
-234
-2% -$11K 0.01% 1152
2019
Q3 		$775K Buy
14,620
+8,129
+125% +$419K 0.01% 1018
2019
Q2 		$343K Buy
6,491
+70
+1% +$3.72K 0.01% 1251
2019
Q1 		$362K Buy
6,421
+110
+2% +$6.17K 0.01% 1225
2018
Q4 		$331K Buy
6,311
+90
+1% +$5.12K 0.01% 1197
2018
Q3 		$359K Buy
6,221
+50
+0.8% +$2.8K 0.01% 1280
2018
Q2 		$350K Buy
6,171
+320
+5% +$18.2K 0.01% 1269
2018
Q1 		$343K Buy
5,851
+2,230
+62% +$125K 0.01% 1163
2017
Q4 		$198K Buy
3,621
+50
+1% +$2.59K ﹤0.01% 1280
2017
Q3 		$168K Buy
3,571
+20
+0.6% +$942 0.01% 1065
2017
Q2 		$165K Buy
3,551
+1,571
+79% +$65.2K 0.01% 946
2017
Q1 		$75K Buy
+1,980
New +$73.3K 0.01% 1031

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State of Alaska Department of Revenue's OFIX Position: Q2 2026 in Review

State of Alaska Department of Revenue held its Orthofix Medical (OFIX) position steady in Q2 2026 at 2,102 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

State of Alaska Department of Revenue first reported a position in OFIX in Q1 2017 and has held it in 31 quarters since. The position peaked at $775K in Q3 2019. 76 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • State of Alaska Department of Revenue held 2,102 shares of Orthofix Medical worth $19K as of Q2 2026.
  • State of Alaska Department of Revenue left its Orthofix Medical share count unchanged in Q2 2026.
  • Orthofix Medical made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #2106 holding.
  • State of Alaska Department of Revenue first reported a position in Orthofix Medical in Q1 2017 and has held it in 31 quarters since.
  • State of Alaska Department of Revenue's Orthofix Medical position peaked at $775K in Q3 2019.
  • 76 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.